Journey Medical Corp insider trading

Every open-market purchase and sale by Journey Medical Corp's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No open-market insider trades reported in the last five years.

Does following Journey Medical Corp’s insiders pay?

From October 6, 2022 to May 5, 2025, 7 insiders reported 9 open-market purchases and 11 sales not made under a pre-set plan in Journey Medical Corp. After sales, the shares moved −5.2% against the index over 12 months (a negative figure means selling was the right call).

Journey Medical Corp: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Maraoui Claude	President & CEO	2	—	—	6	+7.2% (4)	May 5, 2025
Benesch Joseph	CFO	0	—	—	3	−4.8% (3)	May 5, 2025
Rosenwald Lindsay A Md	Director	3	—	—	0	—	March 27, 2024
Paley Jeffrey	Director	2	—	—	0	—	October 10, 2023
Smith Justin Adam	Director	2	—	—	0	—	March 25, 2024
Alloush Ramsey	COO	0	—	—	1	−55.5% (1)	May 5, 2025
De Paolantonio Ernest Robert	Chief Financial Officer	0	—	—	1	—	October 6, 2022

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

When several insiders traded Journey Medical Corp

Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Journey Medical Corp in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After 1 selling crowd, −16.5%. One company's history is too short to judge by; the test across every company is the better guide.

Month	Crowd	3 months on, vs S&P 500	6 months	12 months
May 30, 2025	3 selling	−20.3%	−16.5%	−55.7%

Colours show whether the crowd was right: green when buyers were followed by a rise above the index, or sellers by a fall below it. Total returns from the month end; past patterns are not a forecast.

← Back to Journey Medical Corp · Funds · Politicians